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Sample Abstract (hypothetical numbers used as the project is not yet complete): 
Background: PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with 
Streptococcal infections) has been described in the literature to define a subset of children with 
Obsessive Compulsive Disease (OCD) and/or tic disorders whose neuropsychiatric symptoms 
begin following a streptococcal pharyngeal infection, most likely as a result of an auto-immune 
process. The existence of the entity remains controversial. Post-streptococcal neuropsychiatric 
sequelae have never been studied prospectively with a comparison group or in an outpatient 
pediatrics setting. 
Aims: I) To further assess the association between Group A beta-hemolytic strep (GABBS) and 
neuropsychiatric symptoms to detennine if the exposure of "strep throat" confers a risk (not 
explained by stress itself) to the development of neuropsychiatric symptoms as described by 
parents and the children themselves. 2) If GABBS is found to be associated with neuropsychiatric 
sequelae, to determine the incidence of post-streptococcal neuropsychiatric and abnormal 
behavioral symptoms in an outpatient pediatrics practice and to categorize by symptom type the 
most common neuropsychiatric or behavioral sequelae. 
Methods: Subjects were 796 sick and well children (age 4-11) without psychiatric or neurological 
disease from an outpatient pediatrics practice in upstate New York and their primary care takers. 
At time of emollment: I) all children received a throat culture testing for GABBS; 2) parents were 
administered a questionnaire that asked about demographics as well as the presence or absence of 
recent life stress for the child/family and presence or absence of recent symptoms of obsessive 
compulsive disease, tics, and other abnormal behavioral symptoms in their children; and 3) 
children who were able also completed a 10-item questionnaire about their own thoughts, 
obsessions, and compulsions. Children who cultured positive were treated with appropriate 
antibiotics. Two weeks and 11 weeks after enrollment, parents and children were sent the same 
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questionnaires. The final cohort included 370 children with strep throat ("exposed"), and 426 
children without strep throat ("unexposed," 205 of whom were healthy and 22lof whom presented 
with symptoms of illness). Two-sample t-tests were used to determine whether the mean number 
of survey question endorsements were different at time of enrollment and at time of follow-up in 
the exposed vs. the unexposed groups. Non-parametric testing was used for skewed samples. 
Risk ratios for individual symptoms were calculated to compare the risk of exposure versus non-
exposure to GABHS. Pearson's chi-square tests were performed to determine if the exposed 
versus the unexposed differed for each of the three groups of symptoms (OCD, tics, or abnormal 
behaviors not specified). The incidence of a PANDAS-like syndrome was calculated for this 
cohort based on a dichotomous outcome of a statistically significantly elevated number of 
symptoms present at follow up that were not present at enrollment. 
Results: Parents whose children had throats that cultured positive for GABHS reported a higher 
mean number of neuropsychiatric and abnormal behavioral symptoms than parents whose children 
were strep negative (p<O.O 1 ). RR of streptococcal exposure and three PANDAS symptoms are as 
follows: frequent hand-washing RR= 2.8 (95% CI 1.4-3.4); frequent checking RR=2.2 (95% CI 
1.2-3.1); and unusual separation anxiety RR= 3.1 (95% CI 1.8-4.7). Post-streptococcal sequelae 
were most likely to represent the OCD-like spectrum and abnormal behaviors not specified 
(p=O.Ol, and p=0.03, respectively) with a trend toward tic-like disorders. The incidence of a 
PANDAS-like syndrome in this outpatient practice cohort was lO cases per 370 exposed patients 
who were enrolled (2.7% ). 
Importance: The first prospective study of children to examine post-streptococcal 
neuropsychiatric and abnormal behavioral symptoms has shown that children exposed to GABHS 
do have increased symptoms when compared to both sick and well children without strep throat. 
This research adds strong support to a growing body of literature indicating a post-infectious 
pathophysiology for psychiatric symptomatology. Such findings may contribute to future abilities 
to curb disabling psychiatric symptoms in children. 
Background: 
PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated 
with Streptococcal infections) describes a subset of children with Obsessive 
Compulsive Disease (OCD) and/or tic disorders, like Tourette's Syndrome (TS), 
whose symptoms begin following a streptococcal pharyngeal infection. It is 
important to note that much controversy surrounds PANDAS, and many notable 
researchers doubt that this newly described entity exists for reasons that will be 
discussed later in the manuscript. The research proposed in this manuscript plans 
to address the concerns of the PANDAS skeptics by using rigorous 
epidemiological methods to determine whether the exposure of "strep throat" 
increases risk of subsequent neuropsychiatric symptoms in a prospective cohort 
study. To understand the context of the research plan, a brief discussion of 
PANDAS and the literature describing its research context is necessary. 
Though there is no definitive test, children may be diagnosed with PANDAS 
if they meet the following criteria for the illness1: 
1. Presence of OCD and/or tic disorder 
2. Pediatric onset of symptoms (age 3 until puberty) 
3. Episodic course of symptom severity (waxing and waning) and/or sudden 
onset of symptoms 
4. Association with Group A beta-hemolytic streptococcal infection (determined 
by a positive throat culture for streptococcal infection and/or elevated anti-
streptococcal antibody titer) 
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5. Association with adventitious movements (like chorea or hyperactivity) 
Although the mechanism is largely unknown, PANDAS is believed to be an 
autoimmune disorder triggered by Group A beta-hemolytic streptococcal infection 
(GABHS). The pathogenic theory stems largely from that of rheumatic fever. In 
rheumatic fever the streptococcal infection causes the body to produce antigens, 
which then cross-react with heart valves, joints, and parts of the brain. As a result 
of this effect on the brain, children with rheumatic fever develop Sydenham's 
Chorea (SC), otherwise known as St. Vitus Dance. Sir William Osler actually 
originally observed the relationship between children with St. Vitus Dance and 
OCD when he described "a certain perseverativeness of behavior" in these 
patients1. In the majority of patients with Sydenham' s Chorea, there are new 
OCD symptoms at the time of the onset of SC that resolve when the chorea 
resolves2• While there is much preliminary evidence of an association between 
streptococcal infection and OCD and/or tic disorder, there are many skeptics who 
doubt its existence 3.45 . In 1978, the first probable case of PANDAS was reported 
in a Japanese boy whose Tourette's Syndrome evolved rapidly after a febrile 
illness and improved with prednisone 6• Since that time, much has been published 
on this topic, including several more case reports 7•8•9 and a recently published 
well described case series 10. A systematic clinical evaluation of 50 children who 
met the working diagnostic criteria for PANDAS (outlined above) was published 
in the American Journal of Psychiatry in 1998, rendering PANDAS an 
established, if not particularly well-known, entity1. 
The natural history of PANDAS has not been well described. However, a 
typical case of PANDAS (to the extent that there is one) is that of a school-age 
child who gets strep throat followed in l-12 weeks by sudden onset oftics or 
OCD behaviors, then gradual improvement, followed by sudden recurrence, 
etcetera. When symptoms flare, there is likely to be positive throat cultures or 
high antibody titers. When symptoms abate, there are often negative cultures and 
lower titers. 
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Some researchers, however, call into question the association between 
GABHS and neuropsychiatric disorders in children-suggesting PANDAS is 
merely an "epiphenomenon"3.4·5. Indeed, the veracity of such an association 
between streptococcal infections and neuropsychiatric symptoms is suspect for 
two reasons. The first is that, given how common streptococcal throat is, new 
onset neuropsychiatric syndromes temporally following a strep diagnosis may be 
merely coincidental. One study found that GABHS infects the average child three 
times by the age of 13 11 , and other studies have estimated the GABHS carrier 
state at between 2.5 % 12 and nearly 20% 13 . Second, "nay-sayers" postulate that 
since it is well known that Tourette's and OCD symptoms worsen during periods 
of stress or illness, the noted exacerbations of these problems with streptococcal 
infections may simply be a non-specific reaction to the stress of illness 4. 
However, in making the case that the relationship between GABHS and 
neuropsychiatric disorders is causal as opposed to merely associative, one could 
refer to many of the Bradford-Hill criteria14 (the criteria are referred to here in 
quotation marks). First, there is "consistency" in the literature in the abundance 
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of case reports 7·8•9·10. The relationship is also "biologically plausible" because the 
disorder "behaves" as we know autoimmune processes do 4• The "analogy" of 
Sydenham' s chorea as discussed above strengthens the evidence for a causal link. 
Finally, there is also some research with small n's documenting "reversibility" 
using NIG, steroids, and plasma exchange15 . Contradictory results exist as to 
whether penicillin prophylaxis reduces the number of exacerbations of 
neuropsychiatric symptoms. In their research, Garvey and colleagues found that 
penicillin prophylaxis did not curb exacerbations of symptoms16 but a case series 
studied and published by Murphy and Pichichero indicated that many of the 
children with abnormal behaviors and neuropsychiatric symptoms improved after 
a course of antibiotics 10. Evidence is more lacking in other Bradford-Hill criteria I such as "temporality" (cause precedes effect), "dose response" (large exposures 
are associated with higher rates of disease), "specificity" (one cause leads to one 
effect) or "strength" (large relative risks) 14• 
The fact that GABHS occurs with such frequency in the population and the 
fact that many neuropsychiatric phenomena worsen during periods of acute stress, 
such as illness, underscore the importance of studies with appropriate comparison 
groups to examine the relationship between GABHS and neuropsychiatric 
sequelae. Given that PANDAS has only relatively recently been proposed as a 
diagnostic entity, there are actually few such studies that include comparison 
groups. 
The first study on PANDAS to contain a comparison group occurred in 1993 
after a GABHS outbreak in Providence, RL Kiessling and colleagues noted a 
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temporal relationship between infection and abrupt onset of tics in some patients. 
They noted that in a sample of 50 children, !bose with movement disorders were 
significantly more likely than those without to have evidence of antineuronal 
antibodies in their sera 17 • Then, in 1997, Swedo and colleagues reported that the 
frequency of a serum trait marker for rheumatic fever susceptibility (labeled 
D8117) was significantly higher in both children with PANDAS and children with 
Sydenham's chorea than it was in healthy controls 18. In 1998, a study of 41 
children with TS and 39 controls reported elevated anti-putamen (putamen is a 
brain structure) antibodies (though not elevated antibodies against GABBS) 
amongst the children with TS 19. 
Just last year three other case-control studies were reported. One determined 
that the sizes of certain brain structures (specifically, the caudate, putamen, and 
globus pallidum) were significantly greater in the group of children with 
PANDAS than in healthy controls 20. Another concluded, based on comparisons 
of antistreptococcal antibody titers and basal ganglia volumes in patients 
diagnosed with chronic tic disorder, OCD, and attention-deficit hyperactivity 
disorder (ADBD) versus community controls, that prior associations may have 
been confounded by the presence of ADBD 21 . Finally, a case-control study that 
investigated the clinical and laboratory evidence of GABBS infection in !50 
children with tic disorders versus !50 controls without found that children with 
tics had statistically significantly higher mean ASO titers and higher rates of 
positive throat cultures than children without tics 22• 
Limitations of Previous Work: 
While well controlled, these studies still have limitations. First, and most 
importantly, none prospectively followed a cohort of children to detect incidence 
of PANDAS or measured the relative risk that GABHS confers to such 
neuropsychiatric problems in children. In fact, none except the Peterson, et al, 
study even stated whether subjects were pre-selected for having had a recent, 
recurrent, or chronic infection with GABHS. Second, all included subjects with 
severe neuropsychiatric problems, and, therefore, may not serve the general 
physician as well. These studies may even underestimate the scope of the 
problem by not including transient or mild symptoms as opposed to full-blown 
illnesses that meet diagnostic criteria. Furthermore, the Peterson study used 
patients aged 7-55, so the study was not limited to children (one of the five 
criteria for PANDAS). 
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Another limitation of previous work is that no studies to date have used a 
comparison group to examine whether children with strep throat might be more 
likely to have abnormal behaviors not generally included in the OCD or 
Tourette's symptom spectrum. In their prospective case series of 12 school age 
children who met criteria for PANDAS, Murphy and Pichichero found that 7 of 
the 12 children displayed unusual urination behaviors (urgency and frequency and 
increased wiping without evidence of UTI), and 5 of the 12 displayed age-
inappropriate separation anxiety10• Such findings underscore the need for further 
research to determine if symptoms like these should be considered part of 
PANDAS sequelae. 
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Though many PANDAS skeptics note that the stress of illness (rather than 
strep itself) may exacerbate tics and OCD symptoms, no studies to date have 
examined the potential inter-relationship between stressful life events, strep 
throat, and the development of neurospychiatric sequelae despite a significant 
historical article in the literature that would indicate this as a plausible 
mechanism. A landmark 1962 study by Meyer and Haggerty found that in the 2 
weeks preceding the onset of respiratory infections (including strep throat), the 
rate of stressful events (as reported by the mother) was 3-4 times higher than in 
weeks occurring not prior to onset of infections 23 . Meyer and Haggerty found 
that chronic stress-- as well as acute stress-- was related to streptococcal infection 
rates. It seems possible, then, that neuropsychiatric sequelae to strep throat may 
be reactions to increased stress that we know from Meyer and Haggerty's work 
precedes streptococcal infection rather than an autoimmune response to the 
streptococcal antibodies themselves. Or, to propose a more biopsychosocial 
mechanism, it is possible that it is some combination of the preceding 
(psychosocial) stress and the (biological) autoimmune response that leads to 
PANDAS. In any case, any prospective examination of PANDAS should 
determine parental endorsement (or not) of a recent significant life event. 
Specific Aims: 
Some of the gaps in the causality chain between GABHS and 
neuropsychiatric symptoms come from the lack of prospective studies with 
comparison groups. As previously discussed, studies with comparison groups are 
ll 
critical. Because PANDAS is thought to be a relatively rare phenomenon, large 
numbers of children would need to be followed to find the incidence of PANDAS. 
Under ordinary circumstances, a prospective cohort study to examine the relative 
risk of developing neuropsychiatric symptoms as a result of strep throat would be 
difficult both because of the large sample size required to document a difference 
and because of the usual inherent problems of follow-up. However, in a large, 
primary care practice where strong follow-up is the norm, this would be possible 
and valuable. Furthermore, using a large primary care pediatrician practice (as 
opposed to a neuropsychiatric clinic) as the source of patient recruitment and 
using surveys to query many types of unusual behaviors (as opposed to meeting 
formal diagnostic criteria for these illnesses) would enable us to find transient 
and/or mild illness that might otherwise go undetected. 
Our specific aims are as follows: 
1. To further assess the association between GABHS and neuropsychiatric 
symptoms and/or abnormal behaviors. 
The subjects will form a cohort of both well and sick children who present to their 
primary care pediatrician's office from October to May (the well-documented 
strep season for this practice24). The exposed group will be those with sore throat 
cultured positive for the presence of GABHS and the unexposed group will be a 
combination of those with sore throat that is not culture positive for GABHS as 
well as those who present for well-child care and are also GABHS negative (in 
order to address whether neuropsychiatric symptoms are a reaction to stress or, 
12 
more specifically, illness). We seek to determine if those with strep throat are 
more likely than those without strep throat to develop neuropsychiatric and 
abnormal behavioral symptoms as reported by the parents or the children 
themselves. We will administer surveys to parents asking them about the recent 
occurrence of neuropsychiatric and abnormal behavioral symptoms in their kids. 
We will also administer surveys to children themselves to determine if they report 
abnormal thoughts, anxieties, or compulsive actions. 
Hypothesis: 
Based on the data reported to date, we expect that patients with sore throat 
that is culture-positive for GABHS will have more neuropsychiatric and 
abnormal behavioral symptoms than those who are not culture positive, 
whether or not those in this latter group have a sore throat. 
2. To assess the incidence of a PANDAS-like' syndrome in a primary care 
pediatrician's office in one strep season, well-documented to be September 
through May in Rochester, NY 24• 
Hypothesis: 
Because the incidence of PANDAS has never been tracked, it is impossible to 
know what incidence we will find. We can hypothesize that we will find a 10% 
increase in the number of positive responses to survey questions in the strep 
positive over the strep negative group and over baseline because we expect to 
find incident transient and mild abnormal behavior as well as previously 
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researched documented pathology (personal communication with John March 
and Sue Sweda, NIMH researchers on this topic). Since I will dichotomize the 
outcome in order to define a set of people who have a PANDAS-like syndrome 
versus not and since that outcome will likely represent a number of symptoms 
that is two standard deviations away from not, the true incidence of such a 
syndrome will likely be low (approximately 2-3%). 
3. To assess whether: a) strep throat; b) parental endorsement of a significant life 
event; or c) a combination of a and b, are more associated with PANDAS-like 
symptoms. 
Hypothesis: 
Meyer and Haggerty's landmark 1962 study suggests that reports of 
significant life events increase immediately prior to onset of streptococcal 
infections, calling into question whether it is the strep infection or the 
preceding stress that leads to PANDAS 23• We expect that it will likely be a 
combination of endorsement of a significant life event and strep throat that 
result in PANDAS-like symptoms. 
Secondary Aims: 
1. To the extent that there are a greater number of neuropsychiatric or abnormal 
behavior symptoms in the strep positive as compared with the strep negative 
group, we will attempt to: 1) determine risk ratios for the individual 
* Because we are not performing a structured clinical interview, nor are we using full validated 
surveys for OCD or Tourette's, we will not be able to diagnose these children with PANDAS, 
even according to PANDAS own criteria. 
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symptoms; and, 2) categorize the frequency of symptoms with the type of 
illness they might represent. 
Hypothesis: 
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We expect GABHS to confer a high risk ratio to the following symptoms: 
unusual hand-washing, checking behaviors, and separation anxiety. Though 
overall we expect to find more abnormal behavioral symptoms in both groups 
derived from an outpatient population than we expect to find symptoms of 
OCD or Tourette 's, we do expect that there will be more symptoms that fall 
along the Obsessive-Compulsive Disease-like category than the tic disorder 
or abnormal behavior, not specified, categories in those children from the 
strep positive group. 
2. To assess the feasibility of conducting a prospective cohort study in a primary 
care pediatrics office which might then help to fund a larger-scale study such 
as a PROS (Pediatric Research in Office Settings) study. 
Hypothesis: 
We expect in this large practice well known for its clinical research and with 
excellent follow-up that we will be able to recruit and follow 800 patients. 
This will provide evidence of feasibility for future cohort studies. 
Methods: 
Enrollment: 
Our aim is to enroll 400 patients in each group in order to allow for some 
loss to follow-up and to make sure the study is powered to detect an appropriate 
difference (sample size calculations will be discussed later in the manuscript). 
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Patients will be recruited from two sites of Elmwood Pediatrics Group, a 
large, suburban practice in upstate, NY (at 125 Lattimore Road, Rochester, NY, 
14620, and at 1000 Pittsford-Victor Road, Pittsford, New York, 14534). This 
practice cares for approximately 3000 patients with sore throat in a given strep 
season (September- May) (25% of whom usually have streptococcal infection) 
and approximately 1800 children for well-child care in the relevant age group. 
Patients will be recruited in three ways: 1) posters in the waiting rooms (see 
Appendix A); 2) by the nurse who is escorting them from the waiting room to the 
examination room prior to the doctor's evaluation (the nurse will be reminded of 
the study by a "Carolina blue" sticker on the patient's vitals sheet); and 3) by their 
I 
I primary care provider who will ask them to participate in the study. Providers will be informed of the study by an explanation at practice group meetings. 
Providers will be encouraged to invite all patients they identify with GABHS 
(strep throat) to enroll in the study as well as all patients they see for sore throat 
that is not strep positive and all patients they see in the time period of the study 
whose primary reason for the visit is routine well child care. Patients of both 
gender and all ethnicities will be recruited. Patients will need to be male and 
female children of the age group 4-11 (inclusive). Younger patients are excluded 
because the survey questions that will be used do not pertain to nor are they 
developmentally appropriate to use for children of a younger age group. Older 
patients are excluded because if patients are beyond the age of puberty, they do 
not meet one of the criteria for PANDAS. 
Inclusion Criteria: 
*Seek their primary pediatrics care at Elmwood Pediatrics Group in upstate, NY 
*Be between the ages of 4 and 11 (explained above) 
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*Have a positive culture for Group A beta-hemolytic strep (GABHS) for children 
in the exposed group 
*Have a negative culture for Group A beta-hemolytic strep for children in the 
unexposed group 
Exclusion Criteria: 
*Have ever been diagnosed with a psychiatric or neurological abnormality, such 
as attention-deficit hyperactivity disorder (ADHD), obsessive compulsive disease 
(OCD), chorea, or tics (as this would make it difficult to detect incident rather 
than prevalent cases) or mental retardation (as survey questions might not be 
developmentally appropriate) 
*Have a history of seizures or closed head injury with loss of consciousness (as 
these might predispose to abnormal behavioral or neurological symptomatology) 
Patients who are recruited from the population seeking well-child care and 
who have a positive culture for GABHS but no symptoms of strep throat 
(specifically lymphadenopathy, sore throat, or fever) will be regarded as carriers. 
They will be excluded to avoid misclassification bias. 
In the unexposed group, developing strep throat during the duration of the 
study--within 12 weeks of initial culture--would cross patients over to the exposed 
group, but would not exclude them from the study altogether. 
Study design: Prospective cohort study. 
For patients in the exposed group, subjects will be those who have their 
throats cultured and have positive cultures. For patients in the unexposed group, 
subjects will be drawn from two groups -those that have sore throat who do not 
have positive throat cultures and those whose primary reason for visit is for 
routine well-child care. 
Study Procedure: (see physician and nurse duties, APPENDIX B) 
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Consents: If a patient's parent agrees to participate in the study, the 
primary care provider will alert the study investigator. This person will decide if 
the patient meets eligibility criteria and will undergo the process of informed 
consent. This will be informed consent for adult parents of the children and 
assent for the children themselves. Non-English speaking subjects will not be 
enrolled. All subjects will sign an assent form (see APPENDIX C), and their 
parents will sign a consent form (See APPENDIX D) allowing participation in the 
study. This consent form will not only allow participation in the study detailed 
here, it will also ask parents if they would be willing to be contacted by the 
researchers for a separate study if their children's behavior appears to be 
abnormal based on the surveys they will be filling out. (This separate study would 
have its own protocol and consent. Participation in the separate study would be 
fully voluntary and have no bearing on their continued participation in this study. 
IRB protocol will be submitted separately). 
Potential risks will be outlined in the consent forms. Potential risks are 
few and will occur equally in both the exposed and unexposed groups: 
1. Emotional distress of the throat culture itself. For some children, this mildly 
invasive procedure can invoke some fear. However, someone will perform 
the culture that has experience and training. 
2. Discomfort of the throat culture. For some children, the gag reflex that is 
triggered by culturing the back of the throat, stimulating vomiting, however 
helping children to "pant like a dog" minimizes the gag response. 
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3. Emotional distress of the survey questions. For some parents and children, 
answering questions about neuropsychiatric symptoms or unusual behaviors 
may be embarrassing or emotionally difficult. Participants will be allowed to 
withdraw from the study at any time and parents and children will be 
informed that some positive responses to questions are normal and do not 
necessarily indicate pathology. 
We will try to maintain confidentiality but not anonymity. Of course, 
patients and their parents will be aware of this. All collected data will be kept in 
locked patient files, or on a database that is only accessible by the research 
investigators. All patients will be given a unique identification code. The linkage 
of the identification code and the patients' names will be kept in a locked file and 
will be unavailable to persons not involved in the analysis. Since there is a 
separate study whose enrollment is dependent on results of this study, and since 
certain survey results may indicate the need for further pediatric attention, the 
code will be broken in the case of survey review that indicates abnormal behavior 
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potentially indicative of PANDAS pathology. Parents will be made aware of that 
linkage and the fact that their responses are confidential but uot anonymous. 
Parents will be encouraged to discuss any unusual behavioral or medical 
symptoms with their pediatrician just as they would if they were not part of a 
study and will be informed that surveys will only be periodically~and not 
immediately-- reviewed. 
Since we will not be diagnosing any neuropsychiatric illness as a result of 
this study, it seems unlikely that there will be any loss of insurability to the 
patients or their families as a result of this study's data collection or results. 
Participants will be followed for 12 weeks following their initial throat 
culture. Participants will need to visit the pediatrics office only one time, the time 
of the initial culture, but they and their parents will be told they need to fill out 2 
additional surveys. The initial, and only, office visit should last less than an hour 
beyond the standard amount of time the office visit would have normally lasted. 
The time to fill out additional surveys will be approximately 15 minutes for each 
of two additional surveys. 
If patients' parents endorse certain abnormal psychiatric or behavioral 
symptoms of their children, the code will be broken and their primary care 
physician will be alerted to their need for further attention and for their 
participation in another study that would further evaluate the relationship between 
GABHS and their mental health. If this were to happen, patients would get 
appropriate care for a problem that might otherwise have never been treated or at 
least for which they might have received delayed care. 
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Consents will also discuss other benefits. Patients will be given a total of 
$30 for participating in the research study. This will be prorated as follows: 
Patients will be given $10 if they withdraw or are withdrawn after they and their 
parents have completed the throat culture and I st questionnaire. Patients will be 
given $20 if these events happen after they and their parents have completed the 
2"d questionnaire. The amount will be $30 if this happens after the 3'd 
questionnaire. If children are unable to complete the questionnaires because of 
reading difficulties, there will be no inducement penalty. 
Patients will not incur any costs (other than time) for participating in this 
study beyond what they would have paid for their standard care (visit for sore 
i 
I throat, strep throat, or well child care). All clinic, diagnostic, professional, and laboratory fees related to the study will be covered, and no additional drugs, 
devices, or transportation costs will be necessary. 
Procedural methods: 
All subjects who have signed consents will have their throats cultured by 
health personnel at the practice. Positives will be those that grow GABHS within 
72 hours according to plating techniques described in Pichichero, Hoeger, et al, 
1999 25 Children will be treated for streptococcal infection with antibiotics and 
sore throat not attributed to GABHS according to standard practice in this 
pediatrics primary care group. If children derived from well-child care have 
cultures that are positive for GABHS but do not otherwise have symptoms of 
streptococcal infection (sore throat, fever, and lymphadenopathy), they will not be 
treated for strep and they will be excluded from the study so as to avoid 
misclassification bias. 
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Parents of children in both the exposed and unexposed groups will fill out 
surveys that include demographic questions as well as questions about their 
children's behaviors (See APPENDIX E). These surveys will be completed at 
baseline (time of culture) and mailed to parents 3 weeks and 11 weeks following 
throat culture (initial presentation) to see if there are any endorsed tic, OCD, or 
other abnormal behaviors (including ADHD, separation anxiety, and unusual 
urinary behaviors). Questionnaires will also be given to children of reading age at 
all three time points asking them about unusual thought patterns characteristic of 
OCD of which parents may not be aware (See APPENDIX F). Researchers have 
found that it is important to ask children themselves since parents are often 
unaware of their children's symptoms 26. If children are not old enough to be able 
to read their survey, they may have an adult read the question and then they can 
answer "yes" or "no" on a separate sheet of paper (See APPENDIX G). Children 
at ages 4 or 5 may not be able to participate in this portion of the study. They will 
still be included in the study, and their parents' responses will still be used. 
Surveys will be piloted to at least I 0 parents and children of varying ages to 
determine clarity and feasibility. 
If surveys are not returned within 2 weeks of initial mailing, parents will 
be telephoned and encouraged to fill out the questionnaire. If needed, another 
mailing will be sent (with instructions not to complete if already completed). 
I 
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Surveys will be counted as returned if they are completed within 4 weeks of first 
mailing or 2 weeks of the second mailing. 
If patients who are strep negative and in the exposed group at the 
inception of the study develop GABHS, they will be "crossed over" to the 
exposed group. 
See the following flow chart for a summary of the study protocol: 
Enroll: 
All children ages 4-11 who seek their care at Elmwood Pediatrics Group and visit 
for well or sick care between October, 2001 and May, 2002 
lj.l 
Exclude those who: 
1) Don't speak English or whose parents don't speak English; 2) children have 
ever had a diagnosis of ADHD, OCD, chorea, tics, mental retardation; 3) children 
have a history of seizures or closed head injury resulting in loss of consciousness; 
4) don't agree to participate/sign consents or assents 
lj.l 
At time of enrollment: 
1) Parents sign consents and children sign assents 
2) Child gets cultured for streptococcal infection 
3) Parent answers survey 
4) Child answers survey (if able) 
lj.l 
Two weeks after enrollment: 
1) Parent answers survey again 
2) Child answers survey again (if able) 
lj.l 
Eleven weeks after enrollment: 
1) Parent answers survey again 
2) Child answers survey again (if able) 
Reliability of Measures 
Some of the questions on the parents survey will be derived from the 
previously validated Yale Global Tic Severity Scale 27 , and the questions on the 
child version of the previously validated Yale-Brown Obsessive Compulsive 
Scale 28. Other questions about abnormal child behaviors thought to be 
potentially related to PANDAS 1•10 will be included in the questionnaire in order 
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to determine if they occur more frequently after the exposure of strep throat. I 
will be working with Robert De Vellis, who authored Scale Development: Theory 
and Applications 29 to determine if the questionnaire can become a validated 
scale. Even if it cannot, however, this is unlikely to affect the quality of our 
results. The study does not attempt to identify children who meet diagnostic 
criteria for Obsessive-Compulsive Disease, tic disorders, or any other psychiatric 
illnesses. It merely seeks to determine whether streptococcal infection increases 
the risk for symptoms previously thought to be related to PANDAS. I have thus 
sought to capture symptomatology previously described in the PANDAS 
literature with my questionnaire and have therefore sought the advice of National 
Institute of Mental Health PANDAS researcher Susan Swedo whose work in large 
part brought PANDAS to the peer-reviewed literature scene (personal 
communication with Susan Swedo). 
The reliability of the streptococcal culture is well documented. The Red 
Book 2000, the report of the Committee on Infectious Diseases30, advises that 
throat culture on sheep blood agar can confirm Group A strep infection with a 
false negative culture rate of less than 10% of symptomatic patients when a throat 
swab specimen is obtained properly. Though recovery of GABHS from the 
pharynx does not distinguish patients with true infection from carriers, recent 
study indicates that the carrier rate of strep throat may be as low as 2% among 
healthy children and as low as 4% among children with apparent viral upper 
respiratory infections 12. We will collect data on whether the children who culture 
positive for strep were ill or well on presentation. Furthermore, we are also 
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including both sick and well children in our control (unexposed) group. Both of 
these plans should help to alleviate misclassification bias. Such bias would be in 
favor of the null hypothesis, anyway, so that if we are able to support out 
hypotheses over the null hypotheses, we can be confident in that assertion. 
Statistical Analyses: (For the statistical analyses described here, only analysis of 
the parent- reported data will be described as the child-reported data may or may 
not be able to be analyzed depending on perceived reliability.) 
Responses for all 3 surveys for both the exposed and the unexposed 
subjects will be collected and entered into a Microsoft Access database and then 
imported into a STAT A 6.0 file (Stata Corporation, College Station, TX). One 
outcome measure, then, will be the continuous measure of number of symptoms 
endorsed by parents. I will calculate the mean number of symptoms for survey 
time points 2 and 3 for both the exposed and unexposed groups. 
A baseline mean and standard deviation will be calculated for both the exposed 
and the unexposed groups. The responses for survey time points 2 and 3 will be 
combined into one number. Positives will be symptoms endorsed at either point. 
If a symptom is endorsed at both time points, it will count only once 
Another outcome measure will be dichotomous-and will represent either 
a significant number of neuropsychiatric/behavioral symptoms or not. To define 
"significant," I will use the number of symptoms above baseline endorsed on 
parent questionnaire that is two standard deviations away from the mean for both 
sick and well children. 
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Analysis for Specific Aim 1: To determine the association between GABHS and 
neuropsychiatric symptoms and/or abnormal behaviors. 
For this aim, the continuous outcome of number of abnormal 
symptoms/behaviors will be assessed. I will use the 2-sample t-test of differences 
to answer the following 2 questions: I) Are there baseline differences in the mean 
number of neuropsychiatric and abnormal behavior questions in both the exposed 
and unexposed groups? and, 2) Is there a difference between the change in 
number of symptoms from baseline in the exposed versus the unexposed groups? 
Since the number of symptoms endorsed will likely be on the low end, 
with many in the 0-5 range, I may have to use non-parametric testing for skewed 
samples. Also, for people who do not complete both studies, I may either need to 
drop those persons from the study or I may need to use an alternative strategy that 
allows for repeated measures but counts each survey as an event. A sample table 
might look like the one below (though these numbers are hypothesized and not 
real and are present for demonstration purposes only): 
Sample dummy table 
Non-exposed Exposed 
(n=400) (n=400) p value 




Mean# 3.6 6.4 <0.05 
positive 
endorsements 
Surveys 2 &3 
Analysis for Specific Aim #2: (To the extent that the exposure of GABHS is 
related to neuropsychiatric and abnormal behaviors), to assess the incidence of a 
PANDAS-like' syndrome in a primary care pediatrician's office in one strep 
season. 
To answer this specific aim, I will use the dichotomous measure of 
significant number of symptoms (as described above) and calculate the incidence 
of this cohort. This calculation will be as follows: the number of people 
developed this outcome over the period of time that the cohort lasted divided by 
the number of people who were susceptible (exposed) at the outset. 
*Because we are not performing a structured clinical interview, nor are we using full validated 
surveys for OCD or Tourette's, we will not be able to diagnose these children with PANDAS, 
even according to PANDAS own criteria. 
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Analysis for Specific Aim #3: To assess whether: a) strep throat; b) parental 
endorsement of a significant life event; or c) a combination of a and b, are more 
associated with PANDAS-like symptoms. 
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To address this specific aim, the dichotomous outcome of a significant 
number of symptoms or not will be used (as described above). I will use logistic 
regression analysis to determine whether the endorsement of a significant life 
event, streptococcal infection, or the two in combination are predictors of getting 
a significant number of neuropsychiatric/behavioral symptoms or not. Such 
analysis will also determine whether streptococcal infection adjusted for potential 
confounders is related to neuropsychiatric sequelae. 
Analysis for Secondary Aim #1: To the extent that there are a greater number of 
neuropsychiatric or abnormal behavior symptoms in the strep positive as 
compared with the strep negative group, we will attempt to: 1) determine a risk 
ratio for the individual symptoms; and, 2) categorize the frequency of symptoms 
with the type of illness they might represent. 
To address the first part of this aim, risk ratios will be calculated with 95% 
confidence intervals. 
To address the second part of this aim, I will use individual Pearson's chi 
square tests to answer the question: Are the people in the exposed group different 
from people in the unexposed group with respect to each category of symptom of 
symptom endorsed ("OCD-like," "tic-like," or "abnormal behavior-like")? A 
category will count as endorsed if any symptom in that category is endorsed that 
was not endorsed at baseline. The table below shows hypothesized values. 
% With Positive Endorsements 
Above Baseline 
Non Exposed p value 
exposed 
OCD-like I 10 <0.05 
Tic-like 2 6 >0.05 
Abnormal 2 9 <0.05 
behavior 
Sample Size Estimations: 
Sample size estimation was determined using STAT A 6.0 (Stata Corporation, 
College Station, TX). For our dichotomous outcome, we estimate a needed 
sample size of at least 286 patients in each of the exposed and unexposed groups 
to provide 90% power, with a two-tailed alpha of 0.05 to detect a conservative 
difference 10% difference in proportions (of "PANDAS-like syndrome" rate). 
We assumed that the rate of abnormal behavioral symptoms among controls 
would be 10% and the rate of abnormal behavioral symptoms among those 
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exposed to strep throat would be 20%. We hope to enroll400 to allow for loss-to-
follow-up and to ensure adequate power to appropriately determine results. With 
286 in each group (accounting for loss to follow up), we will have 90% power to 
' 
detect a 10% difference in rate of abnormal behavioral symptoms. With 80% 
power we could detect a statistically significant difference in proportion of 
behavioral symptoms as small as 9% between exposed and unexposed with only 
286 in each group. 
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Our continuous outcome is based on number of symptoms endorsed. If 
we use mean parent -rated symptom score and assume that controls will have a 
mean of 2 abnormal symptoms (where as those exposed will have a mean of 4 
abnormal symptoms), and we assume the standard deviation will be a 
conservative 4, then the sample size needed to detect this difference is only 85. If 
we enroll 250 in each group, we'll be able to say with 99% power that we have 
detected a difference. 
Feasibility of Achieving this Sample Size: 
Since this practice sees approximately 3000 patients with sore throat in a 
given strep season (September- May) (25% of whom usually have streptococcal 
infection) and approximately 1800 children for well-child care in the relevant age 
group and parents are used to participating in studies at this practice (which has 
published over 70 research articles based on studies conducted at the practice), 
patient recruitment at the numbers needed should not be difficult. I will likely 
have adequate power to address my key study question. 
Joanne Garrett, Ph.D., biostatistician and epidemiologist will be helping 
me with the statistical analysis here at UNC-CH. 
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Funding Sources: 
My Robert Wood Johnson Fellowship comes with research support to pay 
research assistants for data entry and to provide supplies such as address labels 
and serial number labels. To pay for throat cultures, a study nurse coordinator 
full-time employed in Rochester, envelopes, postage, and patient incentives, I 
have received intramural funding in the amount of approximately $114,000 from 
the budget of Dr. Sue Sweda, NIMH researcher in the Pediatrics and 
Developmental Neuropsychiatry Branch. 
IRB Approval: IRB Approvals from both UNC and NIHM have already been 
secured. 
Potential significance: 
OCD and tic disorders are not rare illnesses in childhood. One-year 
prevalence rates of OCD have been reported to be as high as 4% in the 
pediatric/adolescent population 31and tics may be present in up to 6% of school 
age children 4. If PANDAS defines a meaningful subset of this population of 
disturbed children (and it is possible that "mild" PANDAS is much more common 
than this even), then it is common enough to warrant further investigation. My 
study will lend further support to the following: 1) the association between Group 
A beta-hemolytic streptococcal infections and their neuropsychiatric sequelae 
through a prospective approach, an approach that many skeptics find critically 
warranted at this point 3.4·5; 2) the theory of an auto-immune pathogenesis, which 
might suggest that these children could benefit from "immune-modifying 
treatment" 4; 3) the biopsychosocial determinants of health; 4) the idea of a 
spectrum of illness; and, 5) the idea of using primary care pediatric practices as 
research settings. 
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In short, we hope this study will lend further support to the association 
between GABHS and neuropsychiatric symptoms and will lend credence to the 
theory of an autoimmune pathogenesis. As an investigation with a comparison 
group, this study will contribute to a growing body of knowledge on autoimmune 
diseases and the role of infectious precursors as well as the growing body of 
evidence that supports the biopsychosocial determinants of illness theory. 
Autoimmune phenomena, of which PANDAS is a postulated example, have a 
known cause, so it would seem likely, then, that the treatments might then be 
specifically targeted toward reducing the infection (antimicrobials) or the body's 
inflammatory response (steroids). The future of gene therapy might also hold 
promise for preventive techniques since D8117 markers are those of genetic 
predisposition toward PANDAS. Teasing apart the relationship between this 
infection and these neuropsychiatric sequelae might potentially serve as a model 
for other such phenomena. 
With frequent surveys of an outpatient population, we hope to find mild and 
transient symptoms -symptoms that might otherwise never come to health 
professional attention. While such symptoms obviously have no long-term or 
diagnostic significance, they might lend further support to a post-infectious 
etiology of psychiatric sequelae. 
Perceived Limitations: 
1) Limited time (only one strep season in which to collect data) 
2) Need a large sample size 
3) Incidence of PANDAS is unknown 
4) Any neuropsychiatric sequelae of strep throat that are found can only be said 
to be "PANDAS-like" since we will not be using formal diagnostic criteria. 
5) The exposure status will not be the on! y difference between groups (i.e. the 
strep exposed group will also be receiving antibiotics) 
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6) There may be some misclassification bias. However, this should bias toward 
the null hypothesis. 
7) Patients will not be blinded to whether they have strep or not. Though the 
investigators will not mention PANDAS, some parents may already be aware 
of PANDAS and the potential association of strep with behavioral symptoms 
and therefore may observe them more in their children, leading to bias. 
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Is your child age 4 -11? 
Is your child here today for either a 
well-child check-up or a sore throat? 
If the answer to these questions is 
"yes," we would appreciate your 
participation in a study about 
children's thoughts, behaviors, and 
movements. 
As part of the study, your child would 
get a throat culture, and you and your 
child would fill out 3 questionnaires. 
Children who participate will receive 
$30. 
If you're interested, please take one of 
these "flags" with you and give it to 
the doctor so we can see if you are 




APPENDIX B- Physician and Nurse Duti2s 
;Enrollment 
Doctor Role 
Be thinking every time you see a patient this fall, winter, and spring for a 
well-child checkup or a sore throat (ESPECIALLY STREP 
THROAT) that you could enroll them in the study (see 
inclusion/excl~-Ision sheet). We need lots of subjects for this sttidy 
to work. 
Refer these patients to a study nurse at the time of the patient visit 
For those Children whom you are swabbing for a rapid strep, do a formal 
throat culture as well 
Study Nurse Role 
Survey# 2 
Fonnal inclusion/exclusion questions of parent- see inclusion/exclusion 
sheet 
Explanation of study to pareht and child~ see nurse coordinator sheet 
Consent of .parent' and assent of child 
Base line surveys. for adults and children 
ThrOat cultures ofchildren who have not already received one (sore 
thro~ts thOught not to be strep and well children) 
Database entry of patient information 
Doctor Role- None 
Study Nurse Role 
Send out surveys 
Log in database whether returned to or not (I will give this information) 
Reminder phone calls for those not returned 
~1y ro.le 
Enter into database responses 
Let study nurse know .. which have been returned and which have not 
Survey #3 
Doctor Role- None 
Study Nurse Role 
Send out surveys 
Log in database whether returned or not (I will give this information) 
Reminder phone calls for those not returned 
My role 
Enter into database responses 
Let study nurse know which have been returned and which have not 
Analysis 
Doctor Role- None 
Study Nurse Role~ None 
My role 
Analyze and write up results 
Before the patients start being enrolled: 
Put study packets together. A study packet should contain the following items: 1) A 
patient information sheet; 2) A parent consent form; 3) A child assent form; 4) A baseline 
parent survey (COLOR); 5) A baseline child survey; 6) Parent survey #2; 7) Child 
survey #2; 8) Parent survey #3; 9) Child survey #3; 10) 2large envelopes with EPG's 
return address and space' fOr parent to fill out his/her address; 11) 2 small envelopes with 
Eliana's address and place for parent to fill out his/her own address; 12) two parent letters 
Prepare envelopes now, except for parent's addresses, which they will do themselves 
(see #11 below). Make sure that the envelopes have appropriate postage on them for the 
number of pages that will be in them. 
Put labels with the same serial number on all items in the packet CINCLUDIN"G 
ENVELOPES) #1-11. Item# 12 (two parent letters) do not need serial numbers on them. 
For each patient: 
1. Make sure each patient meets inclusion criteria and does not meet exclusion criteria 
If a patient meets any one of the exclusion criteria, he/she cannot be a part of the 
study and will not re·ceive his/her own serial number 
2. If patient is to be enrolled, explain to hirnlhe.r the following: 
Elmwood Pediatrics Group and a researcher from the University of North 
Carolina are conducting a study to determine why some children have different 
behaviors, thoughts, or body movements. If you decide to partake in this study, you and 
your child will each answer 3 brief surveys (they should take no more than 5-l 0 minutes 
each) asking about the behaviors, thoughts, and body movements of your child as well as 
a few questions about medications and demographic information. If your child cannot 
read, you will read the questio;s to him/her so that he/she can answer them. Your child 
will also receive a throat culture if he or she hasn't already. Your child will be paid $30 
for his/her participation in the study with your help. Please read the following consent 
form. 
3. Have the parent read and sign the consent form. Make sure that he/she checks the two 
boxes at the end (or at least the one that gives permission for this study). Make sure that 
he or she knows that if there is any problem with the child's behavior throughout the 
study that he or she would otherwise bring the child in for, that they should certainly do 
that (i.e. explain that we researchers will not be looking at the survey forms 
immediately). 
4. Have the child read and sign the assent form. If the child cannot read well enough, 
read it to him or her yourself, showing the parent how you are doing this so that the 
parent can assist the child for survey #s 2 and 3. 
I 
' 
5. Once the parent is consented and the child is assented, give them each copies of their 
consents/assents (these do not need to be signed and may simply be taken from a stack). 
Put the paper work you are not using today (follow-up surveys #2 and #3 for both adult 
and child) into the child's file to be kept in a locked cabinet. 
6. After putting the serial number on the information sheet that corresponds to the serial 
number on all of the pages of the study packet, have the parent begin filling out the 
information sheet. 
7. Have the parent start filling out the survey. 
8. If the child is of reading age, have the child start working on his/her survey. If the 
child is not of reading age, read the questio'(ls to the child and have the child circle "yes" 
or "no" appropriately. Meanwhile, show the· parem how to help the child fill out this 
form because it will be the exact same form for the next two follow-ups. If the child is 
unable to answer, indicate this on the information sheet, so that the children will not be 
mailed this survey in folloW-up. Show the child how he/she can fold the survey and put it 
in the envelope for confidef:ltiality. 
9. As soon as possible, enter the information on the information sheet into the database, 
and put aside the information sheet and consent/assent for safe-keeping in the patient's 
file in a locked cabinet. 
l O.Once the parent and child are each done with their respective surveys, inake sure that 
all questions are answered and put them in a secure envelope. Compile these envelopes 
in a pile for xeroxing. Once xeroxed, put the original forms in one of the large envelopes 
that is addressed to me. Make sure items stay stapled during xeroxing. You will be 
sending me a large envelope each week at the end of the week. 
ll.Ask if the child has had a throat culture yet. If the child has, make sure that it was 
done as a regular culture-not a rapid strep test. If the child has not had a throat culture, 
culture the child's throat with a regular culture-not a rapid. 
l2.Have the parent write his/her address on 2large envelopes for the 2nd and 3rd survey 
mailings (These envelopes should have EPG's return address on them). Have the parent 
also write his/her name as the RETURN address on two smaller envelopes (these will be 
the envelopes that contain the COMPLETED surveys- once they have tilled them out-
that will be sent to me). These two smaller envelopes should have been previously 
addressed (see at the top of this page) to me (Eliana Perrin at UNC). 
13. Tell the parent and child upon leaving the following: 
Thank you very much for enrolling in this study. Remember that we will be mailing you 
surveys just like the one(s) you filled out today on two more occasions. One will be 
mailed to you in 2-3 weeks. Another will be mailed to you in 2-3 months. Please take the 
short time it takes to fill them out promptly (within a week) and return them in the 
addressed and stamped envelope that will be provided. They will be addressed to a 
researcher-at the University of North c;arolina. Don't send them here. And again, if you 
have any concerns about your child, let your pediatrician know. 
14. As soon as possible, enter the information on the information sheet into the database, 
and put aside the information sheet and consent/assent for safe-keeping in the patient's 
file in a locked cabinet. 
15. At the end of each we~k throughout the study: 
Figure out how many patients enrolled that week. E-mail me that number. 
Figure out strep status on each of the children cultured that week (NOTE: for 
children cultured at the end of the week, save their strep status for the following week 
when it will have been growing at least 48 bours) 
Enter strep status into the compute-r database 
Back up the database file 
Make a hard copy 9f the file (put it in locked storage) 
Send me a copy of the back up 
Send me the large:erfvelope addressed to me and stamped that contains Xeroxed 
patient s.urveys. 
Assess which patients need to be sent -out their second round of surveys (see #13). 
Assess which patients need to be sent out their third round of surveys (see #13). 
Assess which patients have not returned surveys within 2 weeks of having been 
mailed them and make a-telephone reminder call (See# 14). 
Note, the data base has many of these items in its reminder "Task list" 
16. For those patients who need to be sent out second or third batch surveys: Enclose the 
cover letter to the parent. Enclose the adult survey and the child survey (or just the adult 
survey if the child was not able to complete the child survey on the baseline attempt) in 
an envelope. Both should be marked with correct serial numbers for the patient. Also 
put one return stamped envelope addressed to me (with the pat[ent's return address on 
this as well) in the envelope. Make sure the appropriate parent address is on the outside 
envelope and make sure the envelope has appropriate postage. Then send it out and 
indicate on the database that you have done so. 
17. I will send you a list each week of the serial numbers of the surveys that have been 
sent back to me. Please enter into the database that they have been returned. If a survey 
has not been returned within 2 weeks of the date it was sent out, please make a note of it 
for the telephone reminder calls. 
18. Make sure that patients receive their incentive ($30) if they completed all 3 surveys. 
Once they have received incentive, mark this in the database. 
APPENDIX C 
University of North Carolina-Chapel Hill 
Assent to Participate in a Research Study 
i\'1inor Subjects 
MedicaliRBStudy# ()f-(V)[J)-31S 
Consent Form Version Date: _07/07/01.-:----
Title of Study: Behavi.or, Tnoughts, and Movement Study 
Principal Investigator: Eliana MiUer Perrin, M.D. 
J Thi,... r~ ........... ,.,t -~,..-~ ..... - '- 1 r h 
TJ1"fC-CH Dep:lrtment: Robert \Vood Johnso_n Clinical Scholars Program & CoiTl.munity 
Pediatrics 
Phone number: 919-966-3776 
Co-Investigators: Marie Lynd M~hY";-:~LD., tvlichael Pichichero, M.D., Janet Casey, M.D., 
Anne Francis, M.D., Carolyn Cleary, M.D., Correne Curtin, M.D., Steven Marsocci, M.D., 
William Hoeger, M.D., Anne Sorrento;PNP, Alice Loveys, M.D., Sue Sweda, M.D. Lisa Snider, 
MD, Joanne Garrett, Ph.D., Desmond Runyan, M.D., Pll.D. 
Sponsor: Robert ·wood Johnson Foundation and National Institute of Health 
The researchers named above are doing a resian;h study. 
These are some thin>::rs we want voU to know :!bout research studies: 
You do noc have to be in this srudy if you don't wam to. 
You may stop being in the study at any time. If you decide to stop, no one will be angry or up~et 
with you. 
Sometimes good things happen to people who take part in studies, and sometimes bad things 
happen. \Ve will telt you more about these things below. 
\Vhv are vou beinO' asked to be in this research studv? 
Because we would like you to be able to help oL.1.er kids who rnighc have behavior problems or 
have trouble with unusual thoughts or movements of their body. 
\Vhv are thev doinO' this resei:lrch studv? 
Because they thin..'c that the answers to the questions we are going to ask your parents and the 
throat culture we are going to do on you might help us to better care for cbildren who have 
behavior problems and unusual thoughts or movement~ of their body. 
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'What will happen during this study? 
This study will take place at Elmwood Pediatrics, which is where you go to the doctor. 
During this study yOu will have a throat culture and you will ansv1er some questions about your 
thoughts. Ymlr parents will also answer questions about you and ways you have been acting. 
Only the doctOrs doing this study will know your answers and they will not be mad at you for any 
of your answers~ 
\.Yhat are the bad thin as that miaht haooen? 
Sometimes things happen to people in ~esearch studies that may make chem feel bad. These are 
called "risks." These are -the riSks of.1hl5 smdy: 
You may gag on the throat culture. sOlne children do. No one will be mad at you if you do. The 
doctor will try to do the throat culture as quickly as pos~ible and teach you some tric~s that help 
some kids not gag on the throat culture. 
YOu may feel embarrassed abo.ut some of the questions that are asked of you or about you, but 
nobody is trying to embarrass you. Nfany normal fhildren answer these questions in many 
different ways. None of your doctors will be mad at you for answering the way that you do. 
Both these things may happen co you or neither of them may happen. Or things may hap[?en that 
tht! doctors don't ~ow about yet. 
'What are the good things that might hUppen? 
People also may have good rhings haf?pen to them because they are in research studies. These are 
called "beneflts." The benefits to you of being in this study may be: 
You might be abte to help other children because you have [?articipaced. 
If you have serious worries, behavior~, or body movements, someone may be better able to hel[J 
you get betLer. 
'Will vou get anY monev for beincr in this research? 
You will be paid SJO for being in this study. 
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"Who should vou ask if vou have anY questions? 
If you have any questions about this study, you may ask the research coordin-ator Who-is the 
person who gave you this fomi.. You may ais? ask your doctor. 
-----------------------------.-----------------------------------------------------------------------------------
If you sign your name below, !t means that yo1,1 agree to take part in this research s-tudy. 
Sign::tture of Research Subject Date 
Signature-of Person ObtaiOing Assent Date 
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APPENDIX D 
University of North Carolina-Chapel Hill 
Consent to Participate in a Research Study 
Parents ofi'flinor Subjects 
MedicaliRBStudy# 0(- m£D-31S 
Consent Form Version Date: _07/07/01 ____ ---,-
Title of Study: Behavior, Thoughts, and Movement Study 
Principal Investigator: Eliana Miller Perrin, M.D. 
------
UNC-CH Department: Community Pediatrics & Robert Wood Johnson Clinical Scholars 
Program 
Phone number: 919-966-1274. 
----~ 
Co-Investigators: Marie Lynd Murph)r, M.D., Michael Pichichero, NLD., Janet Casey, M.D., 
Anne Francis, M.D., Carolyn C)eary, M.D., Correne Curtin, M.D., Steven Marsocci, M.D., 
William HoegeC., M.D., Anne Scirrento, PNP, Alice Loveys, M.D., Sue Sweda, iYLD. Lisa Snider, 
MD, Joanne Garrett, Ph.D., Desmond Runyan, M.D., Dr. PH. 
Sponsor: Robert Wood Johnson Foundation and National Institute of Mental Health 
You are being ·asked to allow your child to take part in a research study. The investigators listed 
above are in charge of the study; other professional.persons may help them or act for them._ 
·what are some oeneral thinos vou should knOw about res~arch studies? 
Research studies are designed to gain scientific knowledge that may-help other people in the 
future. Your child may not receive any direct benefit from participating. There may also be risk.s 
associated with participating in research s!Udies. 
Your child's partic-ipation is voluntary. You may refuse to allow this participation, or may 
wit.1.draw your consent at any time, and for any reason, witl10utjeopardizing your family's future 
care at tpis institution or your relationship with your doctor. If your child is a patient -.vith an 
illness, your child does not have to participate in research in order to receive treatment. 
Details about this particular study are discussed below. It is impon:ant that you understand this 
information so that you can decide in a free and informed manner whether you want your child to 
participate. You will be given a copy of this consent form. You are urged to ask the 
investigators named above, or staff members who may assist them, any questions you have about 
this study at any time. 
\Vhat is the ourpose of this stud-v? 
The purpose of this research study is to determine why some children have different behaviors, 
thoughts, or body movements. 
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How many subjects will participate in this studv? 
Your child will be one of appro&imately 800 subjects in this research study. 
How long will vour child's participation last? 
Your child's participation in this study will last for appro<imately 12 weeks. If your child's 
behavior or movements ilfe'especia11y different from average, you may be asked to have your 
child participate in anothe[ study. That srudy is sep::I.I'ate from this one and you may refuse or 
accept parcici'pation in that study for your child o.t that time. 
VVhat will haopen if vour child takes part in the study? 
During the course of this smdy, the f~I+owing'will occur: 
If he or she hasn't already, your child will receive a throat culture today. lf your child has 
symptoms of strep thro8.t and t~e tm~~-t culture is positive (meaning your child has strep throat) 
he or she will receive antibiotics and appropriate medical care for his/her strep throat. No child 
will be given placebos or sugar pills for any reason. No child will be given any medication for 
strep throat or sore throat that he or she would not otherwise be given if he or she were not in the 
study, and all medications prescribed will be with your full knowledge. 
Whether or not your child has strep throat, you will be given a questionnaire to fill oui 
asking brief demographic questions and 20-30 qu~stions about his/her behavior. thoughts, and 
body movements. If your child is able to read well, he or she will also be given a questionna.Lre 
asking him/her about thoughts, fears, and movements. If your child is unable to read well, we 
may ask you to read the questions to h.irn or her buc not watch hlm or her fill out the answers. n,e 
first of these questionnairess will need to'" be completed by you and your child today before-you 
leave. Then, in 3-4 weeks, the sam·e questionmlires will be mailed to you and your child in 3-4 
weeks. Finally, in ll-12 weeks (about 3ffionths), th.ird questionnaires will be mailed to you and 
your child. The first questionnaire may take 15 minutes to fill out, but the second and third 
should take only about 10 minutes because you will be familiar with them. 
We are asking you the same questions over and over because children's behaviors, 
thoughts, and movements may change over the course of 12 weeks and we want to know if that 
happens. You will need to send back the second and third surveys within a week in order to 
make sure the surveys all get done in the same range of time. You will be given a stamped 
envelope for that purpose so there will be no out of pocket expenses. If you do not mail back the 
survey on time, another survey will be sent to you and possibly one of our research coordinators 
will call you to remind you to fill out the survey. 
You should kr1ow that answering "yes" to some of the questions may be entirely nonnaL 
Surveys will be periodically, BUT NOT IMMEDIATELY, reviewed. If you have answered 
"yes" to certain questions or to many of the questions, your child may have unusual behaviors, 
thoughts or movements thac require further treatment. If this is true, you will be contacted by 
your doctor's oftlce for appropriate fo!low~up. Also, if you answer '"yes" to certain questions or 
to many of the questions, you may be asked on behalfofyourchild to participate in another 
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study. That smdy is separate from this one and you many refuse or accept participatioa in that 
study for your child at that time. 
Your doctor will remain the same during this time, and, as always, if yOu have any 
questions about your child's behavior, thoughts, or movements, you should contact him or her 
JUST AS YOUWOULD IF YOUR CHILD WERE NOT IN THIS STUDY. 
Are there ::mv reasons vour child should not particioate'? 
Your child should not participate in this study if he or she has ever be~n diagnosed with 
obsessive compulsive disease, a proble.m with tics (repetitive, unusual movements), 
attention~deficit hyperactivity-disorder (ADHD), chorea, mental retardation, depression, 
rheumatic fever, or a s~izUre -di~order. . 
Your child should not participite ·in:tbls study if he or she has ever had a head injury with loss of 
consciousness .. 
VVhat are the possible risks or discomforts? 
This study might involve the following risks and!Qr discomforts to your child: 
Occasionally children gag with a throat culture. The throat cultures will be done by health 
personnel at Elmwood pediatrics who are used to doing throat cultures in childrea. He or 
she will do it as quickly as possibie. 
You may feel embarrassed about some o{ the questions that are asked of you about your child, 
but nobody is trying to embarr2.ss you or your child. Nfany parents of normal children 
answer these questions ih many different wJ.ys. Your doctors will not reduce the level of 
care they provide your child based on your answers. 
In addition, there may be uncommon or previously unrecognized risks that might occur that we 
are not aware of yet. 
VVhat are the possible benefits? 
The benefits w your child of participating in this study may be that he or she will help other 
children with unusu::1l behaviors or body movements. You and slhe ffiay- help researchers 
discover the cause of unusual behaviors or body movements. 
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It is possible that if your child does have certain unusual behaviors or movements, he or she 
might be able to get care whereas otherwise, these behaviors or movements might be thought to 
be normal and not receive a physician's attention. 
I£ your child came to the doctor today for a well-child check-up, it is possible that as a result of 
participating in this study, you will determine whether your child is a carrier of strep throat. If 
your child is a carrier, he or she will not be ::1ble to participate further in the study, but you would 
be informed of this. 
·what if we lenrn about new risks ct"urina the studv? 
You will be given any new information_ gained during the course of the study that In.ight affect 
your willingness to continue yo·ur ch.i.td 1s partJcipation. 
How will vour familv's priYacy be protected? 
No subjects will be identified in any report or publication about this study. Although every effort 
will be made to keep research records private, there may be times when federal or state law 
requires the j_i?closure of such records, including personal information. This is very unlikely, bm 
if disclosure is ever required, the University ofNorch Carolina at Chapel Hill will take all steps 
allowable by law to protect the privacy of personal inforrnatiotl. 
\Ve will try to maintain confidentiality but not anonymity. Vi/bat this means is that the 
researchas will be able to know which parent and child filled out which questionnaire, but this 
information will not be told to anyone outside of the research project. All collected data will be 
kept in locked patient files, or on a database that is only accessible by the research investigators. 
All patiencs will be given a uniq'ue identification code that is destroyed once the analysis is 
complete. The linkage of the identification code and the patients' n::unes will be kept in a· lacked 
file and will be unavailable to persons not involved in the analysis. 
However, if your answers to surveys or your child's answers to surveys indicate to us the need to 
contact you to bring your child in for further investigation of any problems, we wiil do so. 
Additionally, if you agree, we may contact you about your child's participation in another study 
that may help to determine why your child is having unusual behaviors or movements. 
Because the National Institute of Health is sponsoring this study, as a governmenc agency, it has 
the right to review all records. 
Because this smdy involves the treatment of a medical condition, a copy of this consent form will 
be placed in your child's medical record. This will allow the doctors caring for your child to 
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obtain information about what procedures he/she is receiving in the study and treat him!her 
appropriately, if he/she has other health problems or needs during the study. 
YYili vou or vour child be paid for participating? 
Your child will receive $30 for participating in this study. If you withdraw at any. time or if you 
are excluded from the study, your child will still be paid for rhe time i_avested so far. For 
example, if your child withdraws after completion of the throat culture and first questionnaire, 
your child will still receive $10. If your child withdraws after completion of the second 
questionnaire, your child will still receive $20. If you and your child participate unr.il the end of 
the study, the full amount of SJO will be paid to your child. 
YYill it cost vou anYthing if vour chird partiCipates? There will be no out-of-pocket expenses 
for you or your far'nily for the throat culture, mailings, or surveys .. All of these items will be paid 
for by the sponsors of this resea~ch. -
YYho is sponsoring this study? 
This research is funded by the National Instituce of Health and the Robert \Yood Johnsorr 
Foundation. The research team is being compensated by the sponsor for conducting the study. 
The researchers do not, however, hold a direct financial incerest in the sponsor or in the proc!-uct 
being studied. 
YVh.at will haopen if vour child is in jured bv this research? 
In the event of personal injury resulting directly from the research procedures, financial 
compensation cannot be provided by The -u nive:rsity of North Carolina at Chapel Hill. L.1. srice of 
all precautions, your child might develop medical complications from participating in this study. 
If such complications arise, the researchers will assist you in obtaining appropriate medical 
treatment but The University Of North Carolina at Chapel Hill does not provide financial 
assistance for medical or other costs. You do not waive any Liability rights for personal injury by 
signing this form. 
\-Vhat if You want to stop before vour child's part in the studv is complete? 
You can withdraw your child from this study at any time. The investigators also have the right to 
stop your child's participation at any rime. This could be because you failed to follow 
instructions, oc because the entire study has been stopped. No matter how or by whom the study 
is stopped, your child will be paid according to the parts you and he or she have completed as 
above. 
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·what ifvou have questions about this studv? 
You and your child have the right to ask, and have answered, any questions you may have about 
th:is research. If you have further questions, or if a research-related injury occurs, you should call 
the study nurse at 716-244-9720. 
·what ifvou have questions ab.out vour child's rights as a subject? 
This research has been reviewed and approved by the Committee on the Protection of the Rights 
of Human Subjects (Medical IRB) at the University ofNorth Carolina at Chapel Hill. If you 
have any questions or concerns regarding your child's rights as a research subject, you may 
contact the Chairman of the Committee at (919) 966-1344. 
------------------------·~~---------------------------------------
Parent's Agreement: 
I.have read the information provided above. I voluntarily agree to allow my child to participate in 
this study. 0 (By checkin'g the box, you indicate your agreement with these statements.) 
I also voluntarily agree to be contacted to participate in another study, depending on my child's 
and my answers to the questionnaires in this study. 0 (By checking the box, you indicate your 
agreement with this statement.) 
Printed Name of Research Subject (Child) 
Signature of Parent Date 
Printed N arne of Parent 
Signature of Person Obtaining Consent Date 
Printed Name of Person Obtaining Consent 
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APPENDIX E- INSThuCIIONS 
Dear Parent or Caregiver-
Enclosed is a questionnaire you have agreed to fill out in participation of the 
Behavior, Thoughts, and Movement Study. You will recognize the 
questionnaire as one you have completed before. It's important that the 
entire questionnaire be completed again, as we are interested to see if 
answers stay the same or change at the 3 time points the questionnaire is 
completed by you (on the day of enrollment, 2-3 weeks following 
enrollment, and 2-3 months following enrollment). 
Also enclosed is a questionnaire foryour child to fill oul Please help your 
child to fill out this questionnaire as you were shown on the day of 
enrollment (do not look at his/her answers and, once finished, fold up the 
questionnaire without looking,at it). If your child was unable to fill out this 
questionnaire even with help on the day of enrollment, then it is not included 
here. 
Once finished with the questionnaire(s), put it (or them) in the stamped, 
addressed envelope provided. Note that the envelope is addressed to Eliana 
Perrin, M.D, who is working on the study along with members of the 
Elmwood Pediatric Group. She is located at University of North Carolina, 
Chapel Hill, CB #7105, Room 5034 Old Clinic Building, Chapel Hill, NC, 
27599 (the address should already be on the envelope). 
Please return these as soon as possible. Your timely response ensures the 
. most accurate information for our study and really helps us. 
If you have any questions about the study, please call the study nurse at 
Elmwood Pediatric Group 716-244-9720. 
Thank you very much for your participation'! 
Your Name: ______________________ _ 
Child's Name:: ________________ ---'---
Child's birth date (rna/day/year): _____ _ 
Address. _____________________ (Street and Apt#) 
------'---------------(City, State, zip) 
Phone Number ( __ )- ___ - ___ _ 
Why is your child here today? (circle one 6_t; the following): 
a. Sore throat 
b. Well-child check-up 
For Study Nurse to Fill Out: 
Patient MR # ____________ _ 
S# ______ _ 
Child able to answer questions at least with help (circle one)? Yes No 
APPENDIX E 
Have the behaviors listed below been true of your child YES NO 
RECENTLY? Check YES only if your child has had the behavior 
for 2 weeks or less. 
I. Do you believe your child has a much harder time paying attention recently? 
' 
2. Do you believe your child has been more fidgety or restless lately? 
3. Does your child seem unusually clingy or have a much harder time being 
sepurnted from you recently? 
4. Has your child recently been more sick with worry recently? 
5. Has your child had unusual fears (such as fear of AIDS or earthquakes or 
something else unlikely to happen) recently? 
6. Hils· y"our child recently asked you more for reassurance? (such as, "Is it oby 
that_?" "Does this mean that something bad is going to happen?") 
7. Hus your child recently had unusual muscle twitches or jerks, sometimes called 
tics. such~~ eye blinking or shoulder shrugs that he or she can't stop? 
8. Has your child recently made unusual noises or sounds over and over again, such 
as throat clearing or barking noises? ' 
. 
9 Has your child recently been checking the same thing over and over again (such 
as whether the door is locked or the oven is oft)? 
10. Has your child wiped herself with toilet paper over and over again recently or 
had any other unusual bathroom routine recently? 
II. Has he or she recently needed to dress a certain way every day? 
12. Has he or she recently needed to wash his or her hands or body a certain way 
every day? 
13. Have you recently heard your dlild sny he or she is still dirty even after washing 
or seem overly worried about germs? 
14. Has your child recently homded things (kept too many things that should be 
thrown out or at least not be kept where your child wa.11ts to keep them)? 
IS. Have you recently tried to stop a behavior that your child repents constantly? 
16. Has your child recently needed to arrange things so they are just right or put 
things in a certain order? 
17. Has your child recently prayed more than other members of the family? 
18. To your knowledge has your child recently had upsetting thoughts that he or she 
can't make go away? 
19. Has your child had unusual urinary probk1ns recently, such as needing go to the 
bathroom urgently, wetting the bed, or hnving daytime accidents"? 
20. Does your child seem more negative about various aspects of life thnn he or she 
used to be? 
Which of the following statements represents your feelings about your child's behnviors: 
a) My child's recent behaviors have not been n problem. 
b) My child's recent behaviors have been a little bit of a problem 
c) My child's recent behaviors have been a moderate problem 
d) My child's recent behaviors have been a severe problem and have meant that we have had to 
change our routine at school or home to compensate·. 
Which of the following statements is true {CIRCLE ONE)"? 
a) My child and/or our family has had a significant life event RECENTLY { e)(amples include death of a 
family member, friend, or pet; divorce or separation of parents: abuse; recent move: recent change of 
schools; recent change in care arrangements) · 
b) My child and/or our family has NOT had a significant life event RECENTLY 
(PLEASE TURN THE PAGE OVER AND ANSWER QUESTIONS ON THE OTHER SIDE) 
Please answer the following questions about your child (JC you have more than one child, please answer 
these and all following questions just about the child that is enrolled in this research study at 
Elmwood Pediatrics): 
How old is your child? 
___ ye~rs old 
Is your child (circle one)? 
a) Male 
b) Female 
Is your child of Hispanic origin? 
a) Yes 
b)No 
Wh~t is your child's race? 
a) _\Vhite 
b) Blaclc/African American 
c) Asian (eg. Chinese. Japanese, South Asian, and South East Asian) 
d) Native Hawaiian/other Pacific Islander 
e) American indian/Alaska Native 
0 Other, specify, ______ _ 
Has your child had strep throat 3 or more times in his or her life? 
a) Yes 
b) No 
To your knowledge, which of the following medicines has your child had in the last 2 weeks? (CIRCLE 
ALL THAT APPLY). 
a) Acetaminophen (Tylenol) 




0 Tylenol Cold 
Now, please answer some questions about you: 
Are you? 
a) Single. never married 
b) Single, separated or divorced 
c) Single, widowed 
d) Married 
What is ynur highest level of education? 
a) Grade school 
b) High school degree 
c) Some college 
d) College degree 
e) At least some graduate school 
g) Tylenol Sinus 
h) Theraflu 
i) Alkaseltzer Cold 
j) Cough medicine (Robitussin, Vicks) 
k) Nyqui! 
I) Benadryl 
What is the highest level of education for your spouse or significant other? 
a) I do not have a spouse or significan( other 
b) Grade school 
c) High school degree 
d) Some college 
e) College degree 
f) At least some graduate school 
To your knowledge, have you or anyone in your f:~mily {parents. spouse. siblings, or children) ~ver had 
rheumatic fever? 
a) Yes 




PLEASE CHECK YES OR NO TO THE QUESTIONS BELOW. YES 
1) Do you worry that you are not clean enough? 
2) Do you think that you have to say certain things over and over 
again or pray a lot to keep bad things from happening? 
·. 
3) Do you have to check things ave~ and over again? 
4) Do you feel you have to go to the bathroom all the time? 
-
5) Do you like to save things (like food or pieces of paper) that 
other people don't think you need to save? 
6) Do you have to count things over and over again? 
. 
7) Do you have to do your homework many times until it is just 
right? 
. 
8) Do you have to get dressed in a certain way every day or put 
your clothes on in a certain order every day? 
9) Do you put things in a certain order or arrange them until they 
are just right? 
10) Do you worry a lot that you or someone you love will die if you 
do something wrong? 
If children are not able to read well enough, parents may read the chart above and 
children will circle yes or no on a separate paper as follows. 
NO 
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!.) YES NO 
2.) YES NO 
3.) YES NO 
4.) YES NO 
c -
5.) YES NO 
6.) YES . NO 
. 
7.) YES NO 
8.) YES NO 
9.) YES NO 
10.) YES NO 
